Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-12

FDA Approved: ESCITALOPRAM — Original Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmaceuticals' original application for escitalopram oxalate, granting approval of a generic escitalopram product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

ORIG AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)